Bedside Genetic or Pharmacodynamic Testing to Prevent Periprocedural Myonecrosis During PCI (ONSIDE TEST)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT01930773
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT01930773
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Hungary, Poland
- Registry status
- Unknown status
Technical summary
Registry record NCT01930773. Randomized; no masking; primary purpose prevention. Start 2013-03 (registry gives no type); primary completion 2019-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Bedside Genetic or Pharmacodynamic Testing to Prevent Periprocedural Myonecrosis During PCI (ONSIDE TEST)
- Acronym
- ONSIDE TEST
- Condition
- Stable Angina
- Intervention (Device)
- Genotyping
- Intervention (Device)
- Phenotyping
- Lead sponsor
- Medical University of Warsaw
- Collaborator
- Polish Cardiac Society
- Collaborator
- University of Pecs
Record details
- Record id
cardio:ct-nct01930773- Content hash
a5a7ea82435693ed9066452577a8feb0b36ea76eb62af73e9ff4eb089459f7ec